Radiation for centrally located lung cancer, tested in 3 treatments
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a safer, lower-dose radiation approach given in three sessions for centrally located lung tumors. It aims to deliver effective treatment while protecting nearby sensitive structures like the heart, esophagus, and major airways.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your lung tumor is 5 cm or smaller and located near major airways or key organs
- Your symptoms and daily functioning are limited enough for an ECOG score of 0 to 2
- You are older than 18 and can sign the study consent form
- You have not had overlapping radiation near this area before (the trial has specific dose limits)
- You do not have a current serious infection, significant lung scarring, or breathing-lung disease called interstitial pneumonia
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special type of focused radiation therapy can effectively treat advanced non-small cell lung cancer (the most common type) as an upfront treatment. It may help patients avoid or delay chemotherapy while controlling their cancer.
This trial tests whether giving high-precision radiation to a few spots that are growing during immunotherapy (with or without chemotherapy) can help people with advanced lung cancer. It aims to see if treating these limited areas of resistance can extend the time the cancer stays under control.
This trial tests whether carbon ion radiation (high-energy targeted radiation) can control peripheral non-small cell lung cancer in people who are medically unable to have surgery. It may help shrink or stop tumor growth while limiting harm to nearby organs.
This trial tests a newer, more precise way of giving radiation for lung cancer tumors that are near the center of the chest. The goal is to see if using a smaller treatment area can reduce side effects while still killing the cancer.
This trial tests whether giving a short, high-dose blast of radiation to the main tumor before standard chemotherapy and radiation can help people with locally advanced lung cancer. It aims to improve how well the cancer is controlled while keeping side effects manageable.
This trial is testing whether giving focused radiation therapy to the main lung tumor, in addition to standard treatments like targeted therapy or chemo-immunotherapy, can help people with advanced lung cancer that has spread to many places. The goal is to see if adding this radiation can improve outcomes without causing too many side effects.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.